Cele mai bune acțiuni farmaceutice de cumpărat 2025

Pharmaceutical stocks consist of businesses focused on the research, development, production, and sale of drugs for the treatment of diseases and conditions. Pharmaceutical stocks have witnessed a surge following the discovery of the Covid-19 vaccine.

This guide highlights some of the best pharmaceutical stocks to buy this year, including the best brokers selling the top pharmaceutical stocks.

List of the best pharmaceutical stocks 2025

1. BioNTech – Best Pharmaceutical Stocks to Buy for Long-Term Gains
2. Johnson & Johnson – Best Pharmaceutical Stocks for Guaranteed Returns
3. Moderna – Best Pharmaceutical Stocks for Future Earnings
4. Novavax – Best Pharmaceutical Company for Major Gains
5. Pfizer – Cheap pharmaceutical stocks under €50
6. West Pharmaceutical – Best-performing pharmaceutical stocks
7. Gilead – Major low-cost pharmaceutical company
8. Bristol Myers Squibb – Top Pharmaceutical Stocks with High Dividend Payouts
9. Otsuka – Best Asian Pharmaceutical Stocks to Watch
10. Teva – Best Pharmaceutical Stocks to Buy for Under €20

You can invest in all of these top pharmaceutical stocks and more on eToro, our recommended stock broker that lets you buy and sell stocks

[stocks_table id=”20″]

A closer look at the best pharmaceutical stocks

Now, let’s see why the top ten pharmaceutical stocks we profiled are worth considering for your portfolio.

1. BioNTech – Best Pharmaceutical Stocks to Buy for Long-Term Gains

BioNTech (short for Biopharmaceutical New Technologies) is a developer and manufacturer of patient-specific, active immunotherapies for the treatment of diseases. Headquartered in Mainz, Germany, BioNTech develops messenger ribonucleic acid (mRNA)-based pharmaceuticals for use in personalized cancer immunotherapies, protein replacement therapies for rare diseases, and engineered cell therapy.

In the wake of the global pandemic, BioNTech partnered with US biotech giant Pfizer to produce its own Covid-19 vaccine. The partnership has proven successful, with the Pfizer-BioNTech Covid-19 vaccine receiving regulatory approval after showing 95% efficacy in adults. The Pfizer-BioNTech vaccine was recently approved for booster shots by the UAE Ministry of Health and Prevention. BNTX has had a stellar year so far. Starting the year at just over €100, BNTX rose to a 52-week high of €463.14 on August 11 before falling. It has failed to recover its previous high since the subsequent plunge. However, BNTX shares have largely traded above its 20-day moving average (MA) of €200 for most of the year.

{etoroCFDrisk} % dintre investitorii de retail pierd bani atunci când tranzacționează CFD-uri cu acest furnizor.

2. Johnson & Johnson (JNJ) – Best Pharmaceutical Stocks for Guaranteed Returns

Holding a top position on the list of multinational biotechnology companies, JNJ is an American multinational company focused on the production of medical devices, pharmaceuticals, and consumer packaged goods. However, JNJ derives most of its revenue from its pharmaceutical business with the immunology drugs Stelara and Tremfya, and the cancer drugs Darzalex and Erleada being its best-sellers.

The healthcare giant has been at the forefront of the fight against the Covid-19 pandemic with its single-dose Janssen vaccine. The product’s appeal has waned since side effects were detected earlier this year. However, Johnson & Johnson is still well-positioned to benefit from the pandemic if the US Food and Drug Administration (FDA) approves Janssen for the entire US population.

For now, Janssen has Emergency Use Authorization (EUA) approval for people 18 years of age and older. JNJ shares have been on an upward trend for most of this year. Starting at €153.49, JNJ has risen 15% to €170.34 in early January. Like many pharmaceutical stocks, JNJ hit a major high in mid-August and has jumped to €178.86, coming off a June low of €160.94. At the time of writing, JNJ shares are trading in the red, following the company’s efforts to gain approval for its Covid-19 vaccine.

{etoroCFDrisk} % dintre investitorii de retail pierd bani atunci când tranzacționează CFD-uri cu acest furnizor.

3. Moderna – Best Pharmaceutical Stocks for Future Earnings

Headquartered in Massachusetts, USA, Moderna is a pharmaceutical and biotechnology giant that focuses on messenger RNA (mRNA)-based vaccine technologies. Moderna’s technology inserts synthetic nucleoside-modified messenger RNA (modRNA) into cells.

The mRNA then reprograms the cells to enable an immune response to external attacks. SpikeVax is approved for use by people aged 18 and over by the US FDA. With an efficacy of 94.1% in adults, SpikeVax has been approved by the European Medicines Agency (EMA) for adults and children aged 12 to 17.

MRNA shares are some of the best-performing pharmaceutical stocks so far this year. MRNA has averaged €200 in volatile markets, after hitting €501.06 on August 10. MRNA is up 264.44% this year, while its price-to-earnings (P/E) ratio for Q2 2021 was €6.46. Following a stock market decline, MRNA is down 40% from its August high and is currently trading at €316.05.

{etoroCFDrisk} % dintre investitorii de retail pierd bani atunci când tranzacționează CFD-uri cu acest furnizor.

4. Novavax – Best Pharmaceutical Company for Major Gains

Based in Maryland, USA, Novavax is a biotechnology company focused on developing vaccines to combat serious infectious diseases. Before the global outbreak of Covid-19, Novavax had developed experimental vaccines for Ebola, influenza, respiratory syncytial virus (RSV) and several others.

Like many others, Novavax has been working on an experimental test for the global pandemic. However, under review by the World Health Organization (WHO), Novavax’s submission is expected to be the first Covid-19 protein subunit vaccine to address the global outbreak. Unlike many vaccines that require sub-zero temperatures to maintain their effectiveness, Novavax injections can be stored at normal refrigerator temperatures (2 to 8 degrees Celsius).

NVAX shares have been largely driven by the vagaries of the market, with major ups and downs. The Maryland-based company entered the year at a high, hitting €331.16 before falling to €156 in early March. A subsequent rally saw it reach €264.72 the following month before falling back to €117.86. Continuing its sporadic rise, NVAX rose once more to €278.50, then fell again and stopped at €165.41.

{etoroCFDrisk} % dintre investitorii de retail pierd bani atunci când tranzacționează CFD-uri cu acest furnizor.

5. Pfizer – Cheap pharmaceutical stocks under €50

Pfizer is one of the best pharmaceutical stocks on the market right now. With top-performing drugs and medical devices like Epipen, an epinephrine auto-injector; Depo-Provera, a contraceptive shot; Dimetapp, a children’s cough medicine; Pfizer has remained at the forefront of global drugs and medical devices since its founding in 1849.

The company boasts a large pipeline of blockbuster drugs that generate over €1 billion in annual revenue. As such, the company has increased its dividend payout over the past 10 years. Income-seeking investors have managed to earn dividends of over 30% over the past five years. Joining the success of biotech companies in the fight against Covid-19, Pfizer has partnered with BioNTech to produce the Pfizer-BioNTech Covid-19 vaccine, which is marketed as Comirnaty.

The drug has been a huge success after FDA approval for people ages 16 and older. A recent CDC approval allows it to recommend booster shots for people ages 18 and older six months after the first shot. Pfizer shares have been rising later than other pharmaceutical stocks.

Trading at an average of €40, PFE shares rose to a 52-week high of €51.96 on August 18, where they encountered price resistance. A rally and subsequent decline saw PFE retest the €51 mark again, but it was unable to break through the price action. PFE lost most of its momentum and slowly slipped back to the €40 range. At the time of writing, PFE is trading below its 20-day MA of €43.90 and is trading at €41.93.

{etoroCFDrisk} % dintre investitorii de retail pierd bani atunci când tranzacționează CFD-uri cu acest furnizor.

6. West Pharmaceutical – Best-performing pharmaceutical stocks

West Pharmaceutical is not a full-fledged pharmaceutical company, but it focuses primarily on the design and production of packaging and delivery systems for injectable pharmaceuticals. Headquartered in Pennsylvania, West Pharmaceutical manufactures rubber components for packaging injectable drugs, thereby providing a sterile environment for manufacturers of drugs such as penicillin and insulin.

Without any direct effort to cure Covid-19, West Pharmaceutical is playing an indirect role in bringing the respiratory disease that originated in Wuhan under control. Its rubber stoppers for vials containing injectable drugs and rubber tips for syringe plungers. Given its vital role in the pharmaceutical industry, West has since purchased new equipment in the states of Pennsylvania and North Carolina to double its capacity for products used with Covid-19 vaccines.

West Pharmaceutical was one of the best performing pharmaceutical stocks and traded above the €350 mark for much of the year. WST shares have seen steady growth and rose to a phenomenal €475.69 on September 9. Since then, WST shares have fallen to €411.99, reflecting the overall market outlook.

{etoroCFDrisk} % dintre investitorii de retail pierd bani atunci când tranzacționează CFD-uri cu acest furnizor.

7. Gilead Sciences, Inc. – Major low-cost pharmaceutical company

Gilead Sciences, Inc. is a biopharmaceutical company headquartered in Foster City, California. Gilead Sciences focuses on the research and development of antiviral drugs used to treat HIV, hepatitis B and C, and influenza, including Harvoni and Sovaldi.

With over 11,800 employees, Gilead Sciences is one of the world’s leading biotech companies and saw its revenue skyrocket from €22.127 billion to €22.449 billion in 2019. Following the outbreak of Covid-19, Gilead Sciences launched Velkury, also known as remdesivir. . Velkury received full approval from the FDA last year and went on to generate over €873 million in revenue for the company. This made it the company’s second best-selling drug in Q3 2020, behind HIV drug Biktravy.

However, a subsequent study published in the Annals of Internal Medicine found that the Velkury vaccine had little “antiviral effect” in hospitalized Covid-19 patients. This prompted the company to halt a Phase 3 study of remdesivir as an intravenous infusion in high-risk patients who were not hospitalized. Gilead based its decision on the “rapidly evolving Covid-19 landscape.”

Despite this, Gilead Sciences saw a 21% increase in its product sales year-over-year (YoY) in Q2, 2021. Sales were mainly fueled by Velkury and Biktarvy, with both drugs pushing revenue to €6.2 billion compared to the same period last year.

{etoroCFDrisk} % dintre investitorii de retail pierd bani atunci când tranzacționează CFD-uri cu acest furnizor.

8. Bristol Myers Squibb (BMY) – Top Pharmaceutical Stock with High Dividend Payouts

Founded in 1858 by Edward Robinson Squibb, Bristol Myers Squibb (BMY) is an American multinational pharmaceutical company. It manufactures prescription pharmaceuticals and biologics in several key areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders.

It is best known for producing the blood-thinning drug Eliquis. Its cancer drug Opdivo, BMY, is also a popular feature in specialty hospitals across the US. Bristol Myers has been expanding and recently acquired drugmaker Celgene in 2019, while adding three more cancer drugs to its portfolio – Revlimid, Pomalyst and Abraxane.

A popular feature in the Fortune 500, Bristol Myers Squibb saw its revenue grow by 63% in 2020. Its dividend payout has remained high, with investors earning 29% over the past five years. BMS was late to the Covid-19 vaccination party, but it has secured global rights to a pair of SARS-CoV-2 antibodies discovered by Rockefeller University. BMY shares have seen periodic rises and subsequent declines. Reaching a high of €69.20, BMY has been on a downward spiral and has seen its value cut by more than 10%. At the time of writing, BMY is precariously sitting at €59.15, below its 20-day MA of €60.30.

{etoroCFDrisk} % dintre investitorii de retail pierd bani atunci când tranzacționează CFD-uri cu acest furnizor.

9. Otsuka – Best Asian Pharmaceutical Stocks to Watch

Japan-based pharmaceutical giant Otsuka Pharmaceutical Co, Ltd is a subsidiary of Otsuka Holdings Co, Ltd. Founded in 2008, it is the second largest drug manufacturer in Japan, after Takeda Pharmaceutical.

The company focuses on addressing medical needs through the research and development of highly innovative medicines and diagnostics. It focuses on meeting medical needs in central nervous system diseases, oncology, cardiovascular and renal areas, tuberculosis, ophthalmology and neurological disorders.

Aiding the fight against Covid-19, Otsuka has collaborated with Denka Company to launch Quick Navi Flu + Covid-19 Ag in Japan. The diagnostic kit is expected to allow medical professionals to easily detect flu and Covid-19 symptoms in patients. The combined kit will be able to obtain these results within a 15-minute evaluation period.

{etoroCFDrisk} % dintre investitorii de retail pierd bani atunci când tranzacționează CFD-uri cu acest furnizor.

10. Teva – Best Pharmaceutical Stocks to Buy for Under €20

Teva Pharmaceuticals is a leading Israeli pharmaceutical company headquartered in Petah Tikva, Israel. Founded in 1901, Teva Pharmaceuticals focuses on the genetic medicine industry and was once the world’s largest generic drug manufacturer before losing its place to Pfizer in 2020. It is the eighteenth largest pharmaceutical company in the world and has operational headquarters in Europe, Australia, North and South America.

Despite its intentions to collaborate with other biotech companies to manufacture a vaccine for the global pandemic, Teva Pharmaceuticals has failed to secure any partnerships so far. According to CEO Kare Schultz, the company’s offer was not accepted and there is a low probability that the healthcare giant will work on a cure.

Meanwhile, Teva has assets under management (AUM) of €10.6 billion and a dividend yield of 3.49%.

TEVA stock started the year at a high but has since declined. Breaking through the range of €13.04 on February 10, TEVA has been on a downtrend since then, with occasional gains. Following its non-participatory role in the fight against Covid-19, TEVA shares hit a yearly low of €8.26 on July 19. A brief rally took it to €10.30 before trading sideways for much of July. However, TEVA has shown resilience and is trading above its 20-day MA of €9.28. It is currently trading at €9.82, with a projected upward trend.

{etoroCFDrisk} % dintre investitorii de retail pierd bani atunci când tranzacționează CFD-uri cu acest furnizor.

Where to buy the best pharmaceutical stocks

Now that you have an overview of the top ten pharmaceutical stocks to buy this month, let’s explore the best trading platforms to buy these stocks. To curate our list, our research focused on platforms that allow you to trade pharmaceutical company stocks. We also considered broker fees, commissions, ease of use, security, and accepted payment methods.

1. eToro – Best Broker for Buying Pharmaceutical Stocks

Founded in 2007, eToro is a popular social trading platform that is highly intuitive, secure, and profitable. Monthly and annual fees are also eliminated, giving you more buying power.

eToro’s popularity has attracted over 20 million global users from 140 countries, thanks to its large repository of investment services. The best pharmaceutical stocks to buy are available on the eToro platform with accompanying exchange-traded funds (ETFs) .

In addition to this, eToro offers exposure to over 17 global financial markets, commodities, FX trading , cryptocurrencies, stocks and bonds. Its “ copy trading ” feature allows less experienced traders to copy the trading moves of professionals. Added to this is “copy portfolio”, which is the platform’s internally managed portfolio. CopyPortfolio helps traders automatically diversify their investments across multiple regions and sectors. This portfolio is often rebalanced based on the best performing sector at that time.

eToro also supports a multitude of payment methods and you can buy your best pharmaceutical stocks via bank transfer, credit or debit card, e-wallet channels like PayPal, Skrill, Neteller and more. The minimum deposit is set at EUR 50 (for US residents), while other regions have to pay EUR 200 to get started.

In terms of security, eToro is a regulated stock broker with operating licenses from ASF, ASIC, CySEC and FINRA in Romania. Users can also file claims for over €85,000 in lost funds in the event of bankruptcy, as it is supervised by the UK FSCS. 

Pro:

Cons:

{etoroCFDrisk} % dintre investitorii de retail pierd bani atunci când tranzacționează CFD-uri cu acest furnizor.

Are pharmaceutical stocks a good investment?

The pharmaceutical industry has been struggling to find a solution to the global pandemic for the past year. With this, all biotech companies have focused their attention on finding a cure, paying less attention to other areas. As a result, their performance has fallen compared to the financial market dominated by stocks like Amazon and Apple. The iShares Biotechnology ETF (IBB) has posted a total return of 27%, compared to the Russell 1000’s total return of 35.1% since September 16.

However, many pharmaceutical companies pay attractive dividends and this may be ideal for you if you are a long-term investor. The long term will not directly affect you as you can let your investment grow over the years. As the world has not escaped the Covid situation, biotech companies will continue to be relevant for some time and the sector will see significant investment in the coming years.

Another key reason to consider portfolio diversification is that the world’s population is aging rapidly. With longer life expectancies, many more people will rely on prescription drugs in the coming years.

Pharmaceutical stocks in the COVID era

Pharmaceutical stocks have become a popular choice for investors as the world grapples with the impact of the Coronavirus. Given the roles and key players in the industry, many see this period as a golden age for the biotechnology sector.

There have been several attempts by different pharmaceutical companies to provide a solution, but there has not been a perfect fit yet, and ultimately, this leaves room for the best to flourish. If any biotech company is able to address the issues related to manufacturing processes, logistics, and most importantly, efficacy, the pharmaceutical company would likely see an explosion in value.

However, pharmaceutical stocks have been sluggish compared to the broader financial markets. This has hurt the sector’s annual returns. Meanwhile, growing confidence and collaboration in finding a cure have allowed pharmaceutical stocks to rise 0.26% on the Dow Jones Pharmaceuticals Index in the US, with shares closing at €708.30. The index is up 8.07% year-to-date (YTD) compared to other sectors, and its one-year gain is pegged at 16.18%.

The S&P Pharmaceuticals Select Industry Index estimates an annual return on investment of 3.34%. However, this figure is expected to change soon. According to a report by Grand View Research, the global biotechnology market is expected to grow at a compound annual growth rate of 15% over the next seven years, reaching 2.44 trillion euros.

Penny Pharmaceutical Stocks

Penny stocks are stocks of small, struggling companies that have underperformed the market. However, this year, penny stocks have become a media darling thanks to the concerted efforts of retail investors.

The pharmaceutical sector has not escaped this phenomenon and we list some of the best pharmaceutical products under €5 that you can add to your portfolio:

• Catalyst Pharmaceuticals focuses on treating rare neuromuscular and neurological diseases. CPRX shares are currently trading at EUR 5.96.
• Acasti Pharma deals with cardiovascular diseases and is a well-known producer of CaPre (omega-3 phospholipids). ACST shares are currently trading at EUR 1.80, up 1.44% in the last 24 hours.
• American Shared Hospital rents state-of-the-art medical equipment to hospitals and medical centers. With a market cap of €10 million, AMS shares are currently trading at €2.74, down 1.08% today.

How to choose the best pharmaceutical stocks for your portfolio

It can be difficult to make a decision on the best pharmaceutical stocks to add to your portfolio. Below, we highlight some criteria to help you get started.

Financial data

The first place to look is the company’s financial history over time. A company can look good financially on the outside and still take on massive debt. This should be a major red flag if you can’t find a way to pay off your credit obligations. A look at the price-to-earnings (P/E) ratio will provide insight into whether the stock is trading at a discount or a premium.

Growth or Constant Dividends

The reason behind the investment will help you decide in this case. If you are driven by the growth of a company then dividends will immediately help you choose the best pharmaceutical stocks for you. If you are looking for growth, penny pharmaceutical stocks might be the best path, while a dividend-focused investment strategy will have you choosing BioNTech and JNJ.

How to buy pharmaceutical stocks on eToro

Now that you’re ready to buy pharmaceutical stocks, we’ll walk you through the process of doing so on the eToro platform. The following steps will take about 10 minutes.

Step 1: Register

Navigate to the eToro website and click on “Sign Up Now” to access the sign-up page. While you’re there, you’ll need to provide your first and last name, email address, and phone number. You’ll also need to choose a strong password.

Step 2: Upload your ID

eToro is a regulated broker, which means you will be required to upload a number of documents as part of the platform’s Know Your Customer (KYC) policies. This can be done online by taking a screenshot of your government-issued ID card or driver’s license. You will also need to upload proof of address which can be a recent utility bill or bank statement.

Step 3: Deposit funds into your account

You will need to meet the minimum deposit limit to access the best pharmaceutical stocks on eToro. The broker accepts:

• Bank transfer
• Debit card
• credit card
• Skrill
• PayPal
• Neteller

Step 4: Buy pharmaceutical stocks

Once the deposit is complete, you are now ready to buy your favorite pharmaceutical stocks. eToro makes this process easy. All you need to do is type in what you want to buy in the search bar. Another option will be to click on the “trading markets” button and select “stocks”.

{etoroCFDrisk} % dintre investitorii de retail pierd bani atunci când tranzacționează CFD-uri cu acest furnizor.

Then click on the “Industry” button and select “Healthcare.” You will be shown a complete list of stocks in that sector. For learning purposes, we will buy shares of JNJ – the largest pharmaceutical company in the world – so we click on “JNJ” and select the “Trade” button.

Step 5: Buy JNJ shares

Now you can buy your shares. Simply enter the amount you are willing to invest (minimum 25 EUR) and confirm the transaction. Don’t forget to set your stop loss and take profit before closing the purchase page.

ConCluSIonS

Pharmaceutical companies are numerous, and the more recognizable brands have been leading the biotechnology sector for several years. Given this, investors are more familiar with the big ones. Given the risk/reward ratio and the pivotal position the world is in, it is still expected that pharmaceutical companies will grow in the coming years. The set of highlighted companies we have covered could provide the necessary financial incentives you are looking for.

If you are looking for pharmaceutical stocks to buy, we recommend using the eToro platform due to its ease of use, and multiple payment methods.

eToro – The Best Platform to Buy Pharmaceutical Stocks

{etoroCFDrisk} % dintre investitorii de retail pierd bani atunci când tranzacționează CFD-uri cu acest furnizor.

Frequently asked questions about pharmaceutical stocks